Tweets
So what’s interesting is that type I IFNs actually tighten the BBB. Is this dysfunctional in SLE? Or does this argue that CI does not correlate with SLE disease activity perhaps? #ACR21 #ACRAmbassador https://t.co/y5x2k3NQFi
Alfred Kim @alhkim ( View Tweet )
4 years 9 months ago
COVaRiPad study - Immunosuppression affects COVID-19 vax Ab levels. 247 pts, 90% seroconverted but @ reduced (3.4 fold) titers. Lowest w/ MMF (21x) and B cell Rx vs MTX/AZA (3-4x). Pts on B cell therapy should wait 6 mos to recv vax #ACR21 Abstr# 0457 https://t.co/1gkCsJSDBk
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Why is lupus nephritis mortality trending up in the US, in contrast to overall SLE mortality?
Race matters
Urban location can make things worse
I'm outside looking in but hope it's not too bold to say disparities affect whether you live or die from LN
#ACR21 ABST0454 @RheumNow https://t.co/wmB9l9fFTT
David Liew @drdavidliew ( View Tweet )
4 years 9 months ago
Dr De Miguel on subclinical large vessel vasculitis in PMR. US assessment. 22% had subclinical GCA. 90% LVV, 10% cranial GCA. Abstr#0466 #ACR21 @RheumNow https://t.co/PDCynMAigi
Richard Conway @RichardPAConway ( View Tweet )
4 years 9 months ago
#ACR21 #ACRbest @RheumNow
Abst#0366 by Garrido-Cumbrera et al. looked at shows that three out of four European axSpA patients have difficulty in finding a job.
swethaann23 @swethaann23 ( View Tweet )
4 years 9 months ago
Interesting study on immune cell profiling in PsA pts
⭐️variability in T cell sub-populations in PsA pts
⭐️no difference in lymphocyte cell populations before/after therapy
Abs#0056
https://t.co/16PYxaxT2S
#ACR21
@RheumNow https://t.co/dWaJr7hJ1p
Robert B Chao, MD @doctorRBC ( View Tweet )
4 years 9 months ago
T2T in AxSpA? ASDAS-qCRP & ASDAS-CRP showed an almost perfect agreement w/ regard to dz activity categories (96%.) Quick ASDAS-qCRP can be used in real time to make clinical decisions. Abs 0374 #ACR21 #RheumNow @RheumNow https://t.co/opOyedQUaZ https://t.co/aeUEsW9HsX
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 9 months ago
Biologic dose tapering in #axialspondyloarthritis in 52% of patients if criteria are met (BASDAI)< 40, physician global score< 40 and no signs of disease activity the previous year, escalation to previous dose if there is a flare @RheumNow #ACR21 Abst#0364 https://t.co/4GntJ6jS11
Dr. Antoni Chan @synovialjoints ( View Tweet )
4 years 9 months ago
Do RA autoantibodies incr the risk of MACE?
In study of ~2000 pts, ⬆️ concentrations of RA-related autoantibodies assoc. w/ MACE and/or CVD-mortality.
Autoantibodies may therefore directly contribute to excess CVD risk in RA...
Abs#0269 #ACR21 @RheumNow
https://t.co/ju3YCRonJt https://t.co/UcOMsYxVMP
Mrinalini Dey @DrMiniDey ( View Tweet )
4 years 9 months ago
Which pt has more MIs post elective surgery? #ACR21 @RheumNow abst#0128
Janet Pope @Janetbirdope ( View Tweet )
4 years 9 months ago
Finally a way to improve Fatigue in RMDs? PLUS it is non pharmaceutical and remote⚡️! Cognitive Behavioural approaches and Personalised Exercise Interventions:
⬇️ Fatigue Severity and Impact
⬆️ Sleep at 1yr in a multiarm RCT.
#OP0462 @RheumNow #ACR2021 https://t.co/5buGCYb5Ut https://t.co/4Wz2VmcL3x
Aurelie Najm @AurelieRheumo ( View Tweet )
4 years 9 months ago
Winning Image Competition: Rheum Dz in Patients of Color: Dermatomyositis #ACR21 @rheumnow https://t.co/OFRDDgQqas
TheDaoIndex @KDAO2011 ( View Tweet )
4 years 9 months ago
